Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedservRegisMAL:MDS 41 12-1 Month Momentum % is 47.73% as of Sep. 01, 2026. GuruFocus rates MAL:MDS with a GF Score™ of 41/100 and a GF Value™ of €0.85 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 1,021 Oil & Gas companies, MedservRegis ranks better than 77.18% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-09-01), MedservRegis's 12-1 Month Momentum % is 47.73%.
The industry rank for MedservRegis's 12-1 Month Momentum % or its related term are showing as below:
MAL:MDS's 12-1 Month Momentum % is ranked better than 77.18% of 1021
companies
in the Oil & Gas industry
Industry Median: 11.26
vs MAL:MDS: 47.73
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
MedservRegis 12-1 Month Momentum % Related Terms
MAL:MDS vs SLB, BKR, HAL: 12-1 Month Momentum % Comparison
For the Oil & Gas Equipment & Services subindustry, MedservRegis's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedservRegis 12-1 Month Momentum % vs Oil & Gas Industry
For the Oil & Gas industry and Energy sector, MedservRegis's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where MedservRegis's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedservRegis (MAL:MDS) has a 12-1 Month Momentum % of 47.73% as of Sep. 01, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on MedservRegis and its competitors. According to the industry distribution chart, MedservRegis ranks #233 out of 1021 companies in the Oil & Gas industry, placing it in the top 22.8%.
Is MedservRegis' 12-1 Month Momentum % too high?
MedservRegis' current 12-1 Month Momentum % is 47.73%. The Oil & Gas industry median 12-1 Month Momentum % is 11.26. MedservRegis' value of 47.73% is 323.9% above this industry median. Based on the distribution chart, MedservRegis ranks #233 out of 1021 companies in the Oil & Gas industry, which is in the top quartile — a strong position relative to peers. Overall, MedservRegis has a GF Score™ of 41/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MedservRegis' 12-1 Month Momentum % compare to SLB and BKR?
According to the Oil & Gas industry distribution chart, MedservRegis ranks #233 out of 1021 companies for 12-1 Month Momentum %. This places MedservRegis in the top 23% of its industry — outperforming the majority of peers. The industry median 12-1 Month Momentum % is 11.26. MedservRegis' value of 47.73% is 323.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for an Oil & Gas company?
The median 12-1 Month Momentum % among Oil & Gas companies is 11.26, based on 1,021 companies in the industry. Companies in the top quartile (top 25%) have a 12-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MedservRegis's current 12-1 Month Momentum % of 47.73% is 323.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on MedservRegis and its competitors. For the Oil & Gas industry, the median 12-1 Month Momentum % is 11.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedservRegis's current 12-1 Month Momentum % is 47.73%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedservRegis stock overvalued right now?
Based on GuruFocus' analysis, MedservRegis (MAL:MDS) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.85, compared to a current price of €0.69 — trading 18.8% below its estimated fair value. The current 12-1 Month Momentum % is 47.73% and 323.9% above the Oil & Gas industry median of 11.26. MedservRegis' overall GF Score™ is 41/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For MedservRegis (MAL:MDS), the current 12-1 Month Momentum % is 47.73% as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MedservRegis (MAL:MDS) Overvalued in 2026?
Based on GuruFocus' analysis, MedservRegis stock appears to be undervalued.
The current stock price of €0.69 is trading 18.8% below its estimated GF Value™ of €0.85.
GuruFocus considers MedservRegis to be Modestly Undervalued.
Key valuation signals for MAL:MDS:
12-1 Month Momentum %: 47.73%
GF Value™: €0.85 vs. price of €0.69 (18.8% below fair value)
Industry Position: 323.9% above the Oil & Gas median (#233 of 1021)
No single metric tells the full story. See the MAL:MDS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MedservRegis PLC is engaged in providing shore-based logistics to the offshore oil and gas industry and engineering and supply chain management for oil country tubular goods (OCTG) to support the onshore oil and gas industry. Its segment includes Integrated logistics support services; Oil country tubular goods; Trading activity and Photovoltaic farms. The company generates maximum revenue from the Integrated logistics support services segment, that Includes the provision of comprehensive logistical support services to the offshore oil and gas industry from the group's bases in Malta, Cyprus, Egypt, South America, and Africa.
41GF Score
Get the complete analysis for MAL:MDS
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MAL:MDS has been successfully added to your 
